NO953458L - Oksazolkinolinonderivater, deres fremstilling og terapeutiske anvendelse - Google Patents

Oksazolkinolinonderivater, deres fremstilling og terapeutiske anvendelse

Info

Publication number
NO953458L
NO953458L NO953458A NO953458A NO953458L NO 953458 L NO953458 L NO 953458L NO 953458 A NO953458 A NO 953458A NO 953458 A NO953458 A NO 953458A NO 953458 L NO953458 L NO 953458L
Authority
NO
Norway
Prior art keywords
oxazolquinolinone
derivatives
preparation
therapeutic use
ch2ome
Prior art date
Application number
NO953458A
Other languages
English (en)
Other versions
NO306617B1 (no
NO953458D0 (no
Inventor
Samir Jegham
Jean-Jacques Koenig
Frederic Puech
Philippe Burnier
Lydia Zard
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO953458D0 publication Critical patent/NO953458D0/no
Publication of NO953458L publication Critical patent/NO953458L/no
Publication of NO306617B1 publication Critical patent/NO306617B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Quinoline Compounds (AREA)
NO953458A 1994-09-05 1995-09-04 Oksazolkinolinonderivater og medikament og farmasöytisk preparat derav NO306617B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9410600A FR2724171B1 (fr) 1994-09-05 1994-09-05 Derives de 3,3a,4,5-tetrahydro-1h-oxazolo(3,4-a)quinolein-1-one, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
NO953458D0 NO953458D0 (no) 1995-09-04
NO953458L true NO953458L (no) 1996-03-06
NO306617B1 NO306617B1 (no) 1999-11-29

Family

ID=9466686

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953458A NO306617B1 (no) 1994-09-05 1995-09-04 Oksazolkinolinonderivater og medikament og farmasöytisk preparat derav

Country Status (28)

Country Link
US (1) US5641785A (no)
EP (1) EP0699680B1 (no)
JP (1) JP4225585B2 (no)
KR (1) KR100392523B1 (no)
CN (1) CN1055472C (no)
AT (1) ATE190311T1 (no)
AU (1) AU687591B2 (no)
CA (1) CA2157427C (no)
CZ (1) CZ286128B6 (no)
DE (1) DE69515402T2 (no)
DK (1) DK0699680T3 (no)
ES (1) ES2145886T3 (no)
FI (1) FI110945B (no)
FR (1) FR2724171B1 (no)
GR (1) GR3033554T3 (no)
HK (1) HK1013652A1 (no)
HU (1) HU218587B (no)
IL (1) IL115276A (no)
NO (1) NO306617B1 (no)
NZ (1) NZ272920A (no)
PL (1) PL184412B1 (no)
PT (1) PT699680E (no)
RU (1) RU2141482C1 (no)
SI (1) SI0699680T1 (no)
SK (1) SK281867B6 (no)
TW (1) TW356467B (no)
UA (1) UA41916C2 (no)
ZA (1) ZA957414B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (en) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
WO2005090309A1 (en) * 2004-03-12 2005-09-29 Wyeth 1,2-dihydroquinoline derivatives and method for using the same to treat hiv infection
NZ579431A (en) * 2007-03-09 2012-04-27 Sanofi Aventis Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
RU2366430C2 (ru) 2007-05-23 2009-09-10 Виктор Иванович Рощин Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
CN105949120B (zh) * 2016-05-27 2018-07-24 广东工业大学 一种四齿螯合型单喹啉衍生物及其制备方法和作为神经退行性疾病的金属离子调节剂的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624861B1 (fr) * 1987-12-21 1990-06-01 Delalande Sa Carbamates tricycliques, leur procede de preparation et leur application en therapeutique
ES2013391A6 (es) * 1989-02-08 1990-05-01 Consejo Superior Investigacion Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles.
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−b酵素阻害活性を有する1,2,4−オキサジアゾール誘導体及びその製造法

Also Published As

Publication number Publication date
ZA957414B (en) 1996-04-15
SK108995A3 (en) 1996-06-05
ATE190311T1 (de) 2000-03-15
HK1013652A1 (en) 1999-09-03
HU9502578D0 (en) 1995-11-28
KR960010648A (ko) 1996-04-20
HUT73435A (en) 1996-07-29
IL115276A0 (en) 1996-01-19
NO306617B1 (no) 1999-11-29
CA2157427C (en) 2010-06-01
DE69515402T2 (de) 2000-10-19
US5641785A (en) 1997-06-24
SI0699680T1 (en) 2000-10-31
ES2145886T3 (es) 2000-07-16
KR100392523B1 (ko) 2003-11-12
CN1128763A (zh) 1996-08-14
EP0699680B1 (fr) 2000-03-08
CZ226295A3 (en) 1996-03-13
CZ286128B6 (cs) 2000-01-12
CN1055472C (zh) 2000-08-16
FI954141A (fi) 1996-03-06
FR2724171A1 (fr) 1996-03-08
GR3033554T3 (en) 2000-09-29
AU3041595A (en) 1996-03-21
PT699680E (pt) 2000-08-31
HU218587B (hu) 2000-10-28
JP4225585B2 (ja) 2009-02-18
PL310273A1 (en) 1996-03-18
NO953458D0 (no) 1995-09-04
TW356467B (en) 1999-04-21
FR2724171B1 (fr) 1997-01-03
DK0699680T3 (da) 2000-08-21
FI110945B (fi) 2003-04-30
IL115276A (en) 1998-12-06
CA2157427A1 (en) 1996-03-06
SK281867B6 (sk) 2001-08-06
EP0699680A1 (fr) 1996-03-06
RU2141482C1 (ru) 1999-11-20
JPH0899881A (ja) 1996-04-16
NZ272920A (en) 1998-03-25
AU687591B2 (en) 1998-02-26
PL184412B1 (pl) 2002-10-31
UA41916C2 (uk) 2001-10-15
FI954141A0 (fi) 1995-09-04
DE69515402D1 (de) 2000-04-13

Similar Documents

Publication Publication Date Title
PT889886E (pt) Novas fenantridinas substituidas na posicao 6
FI945703A0 (fi) 3,4,4-trisybstituoitujen piperidinyyli-N-alkyylikarboksylaattien ja välituotteiden valmistus
PT536515E (pt) Novas 7-substituido-9-(amino substitido)-6-desmetil-6-desoxitetraciclinas
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
ATE370148T1 (de) Halbsynthetische ectein-ascidine
FI925849A0 (fi) Tiazolidinfoereningar, deras framstaellning och terapeutiska anvaendningar
FI925848A0 (fi) Tizolidinfoereningar, som innehaoller en kinogrupp, deras framstaellning och terapeutiska anvaendningar
DK0699680T3 (da) Oxazologuinolinonderivater, deres fremstilling og deres terapeutiske anvendelse
ATE207887T1 (de) Neue n-aryl-2-hydroxy-alkylamide
DE69033342D1 (de) Etoposidanaloge
NO305399B1 (no) 2,3-dihydroksypropyl 2-(1-oksoalkyl)amino-2-deoksoglucopyranosider, deres fremstilling og anvendelse
ATE124686T1 (de) Phenylalkylamine und diese enthaltende fungizide.
FR2716198B1 (fr) Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
FI952203A0 (fi) Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi
RS50791B (sr) Farmaceutske kombinacije zasnovane na derivatima piridoindolona
FI912269A0 (fi) 3'-deamino - 4'deoxi - 4'-amino- 8 -fluorantracykliner och framstaellningsfoerfaranden foer dessa.
FR2682378B1 (fr) Nouveaux derives de l'acide fluoroquinoleine carboxylique-3 et leur preparation.
DE3865521D1 (de) 4-methyl-4-phenyl-1-pentanale, deren herstellung und verwendung als riechstoffe.
ATE12645T1 (de) Phenylethylthiazolderivate, ihre herstellung und ihre anwendung in der therapeutik.
SU1690242A1 (ru) Антифидант

Legal Events

Date Code Title Description
MK1K Patent expired